Financing Cancer Prevention and Treatment in Latin America

Cancer incidence across the region is consistent with global trends, with an estimated 40% rise in the number of cases expected by 2030. Meanwhile, challenges in cancer care exist along the continuum, and finance presents a particular problem as the burden continues to grow. 

This Financial Times webinar, organized in partnership with MSD will bring policy makers, thought leaders, patient advocates and other key stakeholders from across Latin America for an in-depth discussion around sustainable financing along the cancer continuum - from prevention to diagnostics and screening through to treatment - with a specific focus on vaccines as a tool for prevention and how to finance and provide timely access to innovative treatments.  

Prioritization

What are the barriers to and strategies for ensuring prioritization for cancer, including adequate funding to support broad patient access to cancer prevention and treatment?

Investment case

What is needed to build the case for investment along the cancer control continuum from prevention to diagnosis, treatment and survival?

Policy framework

What policy frameworks could create an enabling policy environment for cancer prevention, screening/diagnosis, treatment, and care in Latin America?

Intersectoral collaboration

What partnerships and alliances are needed to drive increased investment in cancer prevention and treatment in Latin America?

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches and strategies to help win market share

FT Live Digital Dialogues - fully digital one hour event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice